Unknown

Dataset Information

0

Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.


ABSTRACT: The tumor suppressor function of the wild-type p53 protein is transdominantly inhibited by tumor-derived mutant p53 proteins. Such transdominant inhibition limits the prospects for gene therapy approaches that aim to introduce wild-type p53 into cancer cells. The molecular mechanism for transdominant inhibition involves sequestration of wild-type p53 subunits into inactive wild-type/mutant hetero-tetramers. Thus, p53 proteins, whose oligomerization specificity is altered so they cannot interact with tumor-derived mutant p53, would escape transdominant inhibition. Aided by the known three-dimensional structure of the p53 tetramerization domain and by trial and error we designed a novel domain with seven amino acid substitutions in the hydrophobic core. A full-length p53 protein bearing this novel domain formed homo-tetramers and had tumor suppressor function, but did not hetero-oligomerize with tumor-derived mutant p53 and resisted transdominant inhibition. Thus, hydrophobic core residues influence the oligomerization specificity of the p53 tetramerization domain.

SUBMITTER: Stavridi ES 

PROVIDER: S-EPMC2144399 | biostudies-other | 1999 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.

Stavridi E S ES   Chehab N H NH   Caruso L C LC   Halazonetis T D TD  

Protein science : a publication of the Protein Society 19990901 9


The tumor suppressor function of the wild-type p53 protein is transdominantly inhibited by tumor-derived mutant p53 proteins. Such transdominant inhibition limits the prospects for gene therapy approaches that aim to introduce wild-type p53 into cancer cells. The molecular mechanism for transdominant inhibition involves sequestration of wild-type p53 subunits into inactive wild-type/mutant hetero-tetramers. Thus, p53 proteins, whose oligomerization specificity is altered so they cannot interact  ...[more]

Similar Datasets

| S-EPMC1170615 | biostudies-other
| S-EPMC4942424 | biostudies-literature
| S-EPMC5565410 | biostudies-literature
| S-EPMC22339 | biostudies-literature
| S-EPMC4155161 | biostudies-literature
| S-EPMC1134950 | biostudies-literature
| S-EPMC125940 | biostudies-literature
| S-EPMC311071 | biostudies-literature
| S-EPMC4403388 | biostudies-literature
| S-EPMC2526250 | biostudies-literature